XML 16 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenues $ 40,923 $ 57,389 $ 128,227 $ 149,896
Cost of goods sold 40,152 53,407 113,830 142,992
Gross profit 771 3,982 14,397 6,904
Research and development expenses 37 37 175 160
Selling, general and administrative expenses 4,563 4,529 12,548 12,715
Operating income loss (3,829) (584) 1,674 (5,971)
Interest expense        
Interest rate expense 5,796 5,396 16,956 15,572
Debt related fees and amortization expense 674 946 2,578 3,565
Accretion of Series A preferred units 1,765 589 4,087 1,509
Loss contingency on litigation 0 0 0 6,200
Other (income) expense 153 (289) 393 (1,001)
Loss before income taxes (12,217) (7,226) (22,340) (31,816)
Income tax expense (benefit) 0 0 (263) 7
Net loss (12,217) (7,226) (22,077) (31,823)
Less: net loss attributable to non-controlling interest 0 (900) 0 (2,832)
Net loss attributable to Aemetis, Inc. (12,217) (6,326) (22,077) (28,991)
Other comprehensive income (loss)        
Foreign currency translation gain (loss) 314 (254) (381) (139)
Comprehensive loss $ (11,903) $ (7,480) $ (22,458) $ (31,962)
Net loss per common share attributable to Aemetis, Inc.        
Basic $ (0.59) $ (0.31) $ (1.06) $ (1.42)
Diluted $ (0.59) $ (0.31) $ (1.06) $ (1.42)
Weighted average shares outstanding        
Basic (in thousands) 20,861 20,554 20,732 20,433
Diluted (in thousands) 20,861 20,554 20,732 20,433